PRMT5 and non-small cell lung carcinoma: As shown in Fig. 1a, b, PRMT5 mRNA expression levels were enhanced in the two most common NSCLC subtypes, lung adenocarcinoma and lung squamous cell carcinoma, as determined using RNA sequencing (RNA-seq) transcriptomic data from The Cancer Genome Atlas (TCGA) database40.